Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 29% ± 15% | |
endothelial cell | 20 studies | 25% ± 10% | |
macrophage | 13 studies | 25% ± 8% | |
basal cell | 13 studies | 26% ± 8% | |
classical monocyte | 10 studies | 24% ± 8% | |
epithelial cell | 9 studies | 25% ± 8% | |
endothelial cell of lymphatic vessel | 8 studies | 34% ± 11% | |
capillary endothelial cell | 8 studies | 23% ± 9% | |
endothelial cell of vascular tree | 8 studies | 20% ± 4% | |
monocyte | 7 studies | 25% ± 14% | |
non-classical monocyte | 7 studies | 21% ± 6% | |
connective tissue cell | 5 studies | 25% ± 7% | |
adipocyte | 5 studies | 33% ± 23% | |
astrocyte | 4 studies | 23% ± 6% | |
pericyte | 4 studies | 32% ± 11% | |
adventitial cell | 4 studies | 25% ± 13% | |
secretory cell | 4 studies | 28% ± 4% | |
squamous epithelial cell | 3 studies | 33% ± 17% | |
endothelial cell of artery | 3 studies | 26% ± 4% | |
glomerular endothelial cell | 3 studies | 36% ± 12% | |
renal alpha-intercalated cell | 3 studies | 30% ± 17% | |
abnormal cell | 3 studies | 39% ± 11% | |
extravillous trophoblast | 3 studies | 77% ± 5% | |
placental villous trophoblast | 3 studies | 41% ± 19% | |
myeloid cell | 3 studies | 25% ± 3% | |
luminal cell of prostate epithelium | 3 studies | 20% ± 5% | |
goblet cell | 3 studies | 24% ± 10% | |
keratinocyte | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 88% | 6964.66 | 78 / 89 | 83% | 205.66 | 751 / 901 |
bladder | 90% | 5762.71 | 19 / 21 | 80% | 75.39 | 403 / 504 |
lung | 93% | 10137.58 | 539 / 578 | 65% | 79.49 | 745 / 1155 |
skin | 97% | 22303.53 | 1755 / 1809 | 53% | 32.23 | 250 / 472 |
esophagus | 75% | 3665.65 | 1081 / 1445 | 70% | 62.00 | 129 / 183 |
intestine | 68% | 3337.83 | 656 / 966 | 66% | 32.71 | 346 / 527 |
thymus | 58% | 3333.16 | 376 / 653 | 74% | 54.29 | 448 / 605 |
uterus | 43% | 2369.44 | 73 / 170 | 87% | 121.00 | 399 / 459 |
breast | 97% | 13492.46 | 447 / 459 | 28% | 14.65 | 309 / 1118 |
adrenal gland | 23% | 1007.84 | 59 / 258 | 78% | 105.27 | 179 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.23 | 1 / 1 |
adipose | 100% | 22253.15 | 1201 / 1204 | 0% | 0 | 0 / 0 |
stomach | 50% | 2346.94 | 179 / 359 | 45% | 18.17 | 128 / 286 |
tonsil | 0% | 0 | 0 / 0 | 91% | 140.08 | 41 / 45 |
peripheral blood | 84% | 8682.41 | 778 / 929 | 0% | 0 | 0 / 0 |
pancreas | 3% | 81.81 | 10 / 328 | 72% | 56.13 | 128 / 178 |
ovary | 34% | 1562.68 | 62 / 180 | 39% | 17.01 | 169 / 430 |
blood vessel | 73% | 6198.47 | 968 / 1335 | 0% | 0 | 0 / 0 |
liver | 34% | 2822.19 | 76 / 226 | 36% | 18.09 | 148 / 406 |
heart | 61% | 4129.90 | 522 / 861 | 0% | 0 | 0 / 0 |
prostate | 22% | 1218.70 | 54 / 245 | 32% | 13.81 | 162 / 502 |
muscle | 52% | 2691.89 | 419 / 803 | 0% | 0 | 0 / 0 |
spleen | 51% | 1927.30 | 122 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 19.74 | 13 / 29 |
brain | 13% | 512.34 | 354 / 2642 | 31% | 31.27 | 221 / 705 |
eye | 0% | 0 | 0 / 0 | 34% | 11.03 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0031623 | Biological process | receptor internalization |
GO_0006954 | Biological process | inflammatory response |
GO_0008283 | Biological process | cell population proliferation |
GO_0008209 | Biological process | androgen metabolic process |
GO_1990410 | Biological process | adrenomedullin receptor signaling pathway |
GO_0007507 | Biological process | heart development |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0035809 | Biological process | regulation of urine volume |
GO_0043116 | Biological process | negative regulation of vascular permeability |
GO_0007165 | Biological process | signal transduction |
GO_0032868 | Biological process | response to insulin |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0001570 | Biological process | vasculogenesis |
GO_0002026 | Biological process | regulation of the force of heart contraction |
GO_0097084 | Biological process | vascular associated smooth muscle cell development |
GO_0031100 | Biological process | animal organ regeneration |
GO_0031102 | Biological process | neuron projection regeneration |
GO_0007565 | Biological process | female pregnancy |
GO_0042594 | Biological process | response to starvation |
GO_0003073 | Biological process | regulation of systemic arterial blood pressure |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0001666 | Biological process | response to hypoxia |
GO_0001843 | Biological process | neural tube closure |
GO_0060670 | Biological process | branching involved in labyrinthine layer morphogenesis |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0002031 | Biological process | G protein-coupled receptor internalization |
GO_2001214 | Biological process | positive regulation of vasculogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0045906 | Biological process | negative regulation of vasoconstriction |
GO_0048589 | Biological process | developmental growth |
GO_2000184 | Biological process | positive regulation of progesterone biosynthetic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0005179 | Molecular function | hormone activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0031700 | Molecular function | adrenomedullin receptor binding |
Gene name | ADM |
Protein name | Pro-adrenomedullin Pro-adrenomedullin [Cleaved into: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)] Adrenomedullin |
Synonyms | AM |
Description | FUNCTION: AM and PAMP are potent hypotensive and vasodilatator agents. Numerous actions have been reported most related to the physiologic control of fluid and electrolyte homeostasis. In the kidney, am is diuretic and natriuretic, and both am and pamp inhibit aldosterone secretion by direct adrenal actions. In pituitary gland, both peptides at physiologically relevant doses inhibit basal ACTH secretion. Both peptides appear to act in brain and pituitary gland to facilitate the loss of plasma volume, actions which complement their hypotensive effects in blood vessels. |
Accessions | P35318 ENST00000524948.5 E9PQE6 E9PL83 ENST00000534464.1 ENST00000530439.1 ENST00000528655.5 ENST00000526492.4 E9PML4 E9PQT2 ENST00000525063.2 ENST00000528544.1 ENST00000278175.10 |